Aurobindo Pharma announced that the company has received final approval from the U.S. Food & Drug Administration to manufacture and market ertapenem injection 1 g/vial. Aurobindo’s ertapenem injection is a generic equivalent of Merck Sharp & Dohme Corp’s Invanz Injection.
Eli Lilly’s ultra rapid lispro (URLi) led to improved and sustained blood sugar control after meals in people with type 1 and type 2 diabetes, according to results from three phase 1b studies evaluating URLi compared to Humalog.
AllianceRx Walgreens Prime, the combined central specialty and home delivery pharmacy formed by Walgreens and pharmacy benefit manager Prime Therapeutics LLC (Prime) announced today a collaboration with Inovalon, a leading technology company providing cloud-based platforms empowering data-driven hea
Today, the U.S. House of Representatives passed a legislative package, SUPPORT for Patients and Communities Act (H.R. 6), which requires electronic prescribing (e-prescribing) of controlled substances in Medicare.
ARLINGTON, Va. – Legislation backed by the National Association of Chain Drug Stores (NACDS) to help address the opioid abuse epidemic was passed today by the House of Representatives. The bill – the Every Prescription Conveyed Securely Act (H.R.
CVS Health has issued the following statement regarding Ohio Department of Medicaid’s report on PBM performance for managed care plans: “CVS Health is pleased that a report issued today that was commissioned by the Ohio Department of Medicaid (ODM) on pharmacy benefit manager (PBM) performance for t
Pharmacy Quality Solutions (PQS), a leading provider of quality measurement and performance information for payer and pharmacy organizations, is helping pharmacies improve the quality of medication use for patients through its flagship platform EQuIPP.
CVS Health president and chief executive officer Larry Merlo will join an exceptional mix of business experts and thought leaders who will share their insights on the accelerated pace of change in health care and how innovation, investments in technology, emerging business models and new competition
CVS Health has expanded its safe medication disposal program to select CVS Pharmacy locations in Arizona to help facilitate proper and timely disposal of opioids and other medications that could be diverted or misused if left in medicine cabinets.
CVS Pharmacy announced that prescription delivery is now available from CVS Pharmacy locations nationwide.
New research from Avalere finds that the amount of prescription opioids sold across the US declined by 11% in 2017 compared to 2016.
Humana Inc. and Walgreens have partnered to provide easier access to primary care and other services for seniors as part of the two companies’ ongoing and shared commitment to the health and well-being of people in the Kansas City area.
Glenmark Pharmaceuticals announced that the U.S. Food & Drug Administration provided its first supplemental Abbreviated New Drug Application (sANDA) approval for the company’s manufacturing facility in Monroe, N.C.
Mylan N.V. announced the U.S. launch of bivalirudin for injection, 250 mg single-dose vial, a generic version of Angiomax from The Medicines Company. The product is a direct thrombin inhibitor indicated for use as an anticoagulant in patients.
Aurobindo Pharma Limited has launched sildenafil sitrate tablets 25 mg, 50 mg, and 100 mg upon receiving final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application.
Dr. Reddy’s Laboratories announced today that it has received final approval from the U.S. Food and Drug Administration (USFDA) and is launching buprenorphine and naloxone sublingual film, 2 mg/0.
